Kumi OZAKI, Satoshi FUNAYAMA, Yukichi TANAHASHI, Shintaro ICHIKAWA, Satoshi GOSHIMA
{"title":"Gd-EOB-DTPA增强MR对肝脏良性肿瘤和非肿瘤病变诊断的影响","authors":"Kumi OZAKI, Satoshi FUNAYAMA, Yukichi TANAHASHI, Shintaro ICHIKAWA, Satoshi GOSHIMA","doi":"10.2463/jjmrm.2023-1801","DOIUrl":null,"url":null,"abstract":"Gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid is a hepatobiliary-specific contrast agent used for enhanced magnetic resonance imaging (EOB-MRI). It can provide specific information on hepatobiliary phase images. In addition to dynamic contrast studies, it is excellent for the detection and characterization of liver lesions.","PeriodicalId":471579,"journal":{"name":"Nihon Jiki Kyōmei Igakkai zasshi","volume":"180 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Impact of Gd-EOB-DTPA Contrast-enhanced MR Imaging on the Diagnosis of Benign Neoplastic and Non-neoplastic Liver Lesions\",\"authors\":\"Kumi OZAKI, Satoshi FUNAYAMA, Yukichi TANAHASHI, Shintaro ICHIKAWA, Satoshi GOSHIMA\",\"doi\":\"10.2463/jjmrm.2023-1801\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid is a hepatobiliary-specific contrast agent used for enhanced magnetic resonance imaging (EOB-MRI). It can provide specific information on hepatobiliary phase images. In addition to dynamic contrast studies, it is excellent for the detection and characterization of liver lesions.\",\"PeriodicalId\":471579,\"journal\":{\"name\":\"Nihon Jiki Kyōmei Igakkai zasshi\",\"volume\":\"180 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nihon Jiki Kyōmei Igakkai zasshi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2463/jjmrm.2023-1801\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Jiki Kyōmei Igakkai zasshi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2463/jjmrm.2023-1801","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Impact of Gd-EOB-DTPA Contrast-enhanced MR Imaging on the Diagnosis of Benign Neoplastic and Non-neoplastic Liver Lesions
Gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid is a hepatobiliary-specific contrast agent used for enhanced magnetic resonance imaging (EOB-MRI). It can provide specific information on hepatobiliary phase images. In addition to dynamic contrast studies, it is excellent for the detection and characterization of liver lesions.